Form 4 Tracker
Rapport Therapeutics, Inc.
RAPP

40 insider filings · Latest: Oct 6, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 7, 2026Oct 8 8:07 PMAbraham CeesayDirector, Chief Executive Officer
Sale
1,147$30.66$35.2K452,245(D)

View →

Oct 6, 2026Oct 8 8:07 PMAbraham CeesayDirector, Chief Executive Officer
Sale
3,375$32.03$108.1K453,392(D)

View →

Oct 6, 2026Oct 6 10:18 PMAbraham N. Ceesay
Proposed Sale
39,470$31.15$1.2M—

View →

Sep 30, 2026Oct 1 8:30 PMCheryl GaultChief Operating Officer
Sale
10,000$33.19$331.9K139,914(D)

View →

Sep 30, 2026Sep 30 8:20 PMCHERYL GAULT
Proposed Sale
10,000$33.02$330.2K—

View →

Sep 23, 2026Sep 24 8:05 PMAbraham CeesayDirector, Chief Executive Officer
Sale
2,210$39.17$86.6K456,767(D)

View →

Sep 8, 2026Sep 9 8:05 PMAbraham CeesayDirector, Chief Executive Officer
Sale
8,210$45.61$374.5K458,977(D)

View →

Aug 25, 2026Aug 26 8:05 PMAbraham CeesayDirector, Chief Executive Officer
Sale
18,921$49.57$938.0K467,187(D)

View →

Aug 25, 2026Aug 26 8:00 PMKrishnaswamy YeleswaramChief Development Officer
Sale
37,000$50.64$1.9M195,862(D)

View →

Aug 24, 2026Aug 26 8:00 PMKrishnaswamy YeleswaramChief Development Officer
Sale
13,160$50.00$658.0K232,862(D)

View →

Aug 25, 2026Aug 25 8:29 PMKRISHNASWAMY YELESWARAM
Proposed Sale
37,000$49.33$1.8M—

View →

Aug 24, 2026Aug 24 8:28 PMKRISHNASWAMY YELESWARAM
Proposed Sale
11,472$48.24$553.4K—

View →

Aug 19, 2026Aug 20 8:09 PMKrishnaswamy YeleswaramChief Development Officer
Sale
404$49.90$20.2K246,022(D)

View →

Aug 19, 2026Aug 19 8:38 PMKRISHNASWAMY YELESWARAM
Proposed Sale
2,092$49.01$102.5K—

View →

Aug 11, 2026Aug 12 8:35 PMAbraham CeesayDirector, Chief Executive Officer
Sale
28,958$48.01$1.4M486,108(D)

View →

Aug 10, 2026Aug 12 8:35 PMAbraham CeesayDirector, Chief Executive Officer
Sale
22,541$46.26$1.0M515,066(D)

View →

Jul 27, 2026Jul 29 8:05 PMAbraham CeesayDirector, Chief Executive Officer
Sale
2,210$42.11$93.1K537,607(D)

View →

Jul 14, 2026Jul 15 8:15 PMAbraham CeesayDirector, Chief Executive Officer
Sale
8,210$40.00$328.4K539,817(D)

View →

Jun 30, 2026Jul 1 8:10 PMCheryl GaultChief Operating Officer
Sale
10,000$41.58$415.8K149,914(D)

View →

Jun 29, 2026Jul 1 8:05 PMAbraham CeesayDirector, Chief Executive Officer
Sale
8,220$39.83$327.4K548,027(D)

View →

Page 1 of 4

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 10, 2026Jun 10 9:57 PMJohn MaraganoreDirector
Grant/Award
15,200$35.2115,200(D)

View →

Jun 10, 2026Jun 10 9:52 PMRobert J PerezDirector
Grant/Award
15,200$35.2115,200(D)

View →

Jun 10, 2026Jun 10 9:46 PMSteven M PaulDirector
Grant/Award
15,200$35.2115,200(D)

View →

Jun 10, 2026Jun 10 9:28 PMPaul M SilvaDirector
Grant/Award
15,200$35.2115,200(D)

View →

Jun 10, 2026Jun 10 9:26 PMJames HealyDirector
Grant/Award
15,200$35.2115,200(D)

View →

Jun 10, 2026Jun 10 9:25 PMReid M HuberDirector
Grant/Award
15,200$35.2115,200(D)

View →

Jun 10, 2026Jun 10 9:24 PMWendy B. YoungDirector
Grant/Award
15,200$35.2115,200(D)

View →

Jun 10, 2026Jun 10 9:23 PMRamiro SanchezDirector
Grant/Award
15,200$35.2115,200(D)

View →

Feb 19, 2026Feb 20 12:05 AMDavid BredtChief Scientific Officer
Option Exercise
6,000$1.8088,080(D)

View →

Feb 2, 2026Feb 4 9:15 PMJeffrey SevignyChief Medical Officer
Grant/Award
130,000$27.75130,000(D)

View →

Feb 2, 2026Feb 4 9:14 PMAbraham CeesayDirector, Chief Executive Officer
Grant/Award
428,000$27.75428,000(D)

View →

Feb 2, 2026Feb 4 9:12 PMTroy A. IgnelziChief Financial Officer
Grant/Award
148,000$27.75148,000(D)

View →

Feb 2, 2026Feb 4 9:11 PMKrishnaswamy YeleswaramChief Development Officer
Grant/Award
120,000$27.75120,000(D)

View →

Feb 2, 2026Feb 4 9:09 PMDavid BredtChief Scientific Officer
Grant/Award
103,000$27.75103,000(D)

View →

Feb 2, 2026Feb 4 9:02 PMCheryl GaultChief Operating Officer
Grant/Award
132,000$27.75132,000(D)

View →